• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类药物(包括新一代药物普拉佐米星)对布鲁氏菌属的体外杀菌活性

In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.

机构信息

Bacterial Diseases of Livestock Research Unit, National Animal Disease Center, Ames, IA 50010, USA.

Department of Biomedical Sciences, Iowa State University, College of Veterinary Medicine, 2028 Vet Med, Ames, IA 50011, USA.

出版信息

Int J Antimicrob Agents. 2015 Jan;45(1):76-8. doi: 10.1016/j.ijantimicag.2014.09.011. Epub 2014 Oct 18.

DOI:10.1016/j.ijantimicag.2014.09.011
PMID:25459738
Abstract

Plazomicin is a next-generation aminoglycoside with a potentially unique set of clinical characteristics compared with other aminoglycosides. This study assessed the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of plazomicin against 15 clinical isolates as well as three reference strains representing Brucella abortus, Brucella melitensis and Brucella suis. These data were compared with those obtained for six other aminoglycosides and two aminocyclitols. Plazomicin and gentamicin were the only drugs demonstrating bactericidal activity towards two of the three Brucella spp., whilst plazomicin was the only drug exhibiting bactericidal activity against B. suis. This is the first study to assess the bactericidal nature of plazomicin against Brucella spp. in vitro.

摘要

泊沙康唑是一种新型氨基糖苷类药物,与其他氨基糖苷类药物相比,具有潜在独特的临床特征。本研究评估了 15 株临床分离株以及 3 株代表布鲁氏菌属 abortus、melitensis 和 suis 的参考菌株对泊沙康唑的最小抑菌浓度(MIC)和最小杀菌浓度(MBC)。这些数据与另外六种氨基糖苷类药物和两种氨基环醇类药物的数据进行了比较。泊沙康唑和庆大霉素是仅有的两种对三种布鲁氏菌属中的两种显示杀菌活性的药物,而泊沙康唑是唯一对 B. suis 显示杀菌活性的药物。这是首次评估泊沙康唑在体外对布鲁氏菌属的杀菌特性。

相似文献

1
In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.氨基糖苷类药物(包括新一代药物普拉佐米星)对布鲁氏菌属的体外杀菌活性
Int J Antimicrob Agents. 2015 Jan;45(1):76-8. doi: 10.1016/j.ijantimicag.2014.09.011. Epub 2014 Oct 18.
2
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.比较新型氨基糖苷类药物普拉佐米星与庆大霉素、妥布霉素和阿米卡星。
Expert Rev Anti Infect Ther. 2012 Apr;10(4):459-73. doi: 10.1586/eri.12.25.
3
Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis.绵羊附睾和牛型布鲁氏菌氨基糖苷类耐药株的流行率:系统评价和荟萃分析。
Braz J Microbiol. 2024 Mar;55(1):429-439. doi: 10.1007/s42770-023-01233-6. Epub 2024 Jan 16.
4
Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae.评估普拉佐米星和对照药物对多重耐药肠杆菌科的杀菌活性。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00236-18. Print 2018 Aug.
5
Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms.比较普拉佐米星与其他氨基糖苷类药物对来自欧洲和邻近国家的分离株的活性,包括对氨基糖苷类修饰酶和其他耐药机制进行分子特征分析的肠杆菌科。
J Antimicrob Chemother. 2018 Dec 1;73(12):3346-3354. doi: 10.1093/jac/dky344.
6
Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.来自巴西50个医疗中心的产碳青霉烯酶肠杆菌科细菌对普拉唑米星的抗菌活性。
Diagn Microbiol Infect Dis. 2018 Mar;90(3):228-232. doi: 10.1016/j.diagmicrobio.2017.11.004. Epub 2017 Nov 10.
7
Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.普拉唑米星与其他抗生素联合使用对多重耐药肠杆菌科细菌的活性。
Diagn Microbiol Infect Dis. 2018 Dec;92(4):338-345. doi: 10.1016/j.diagmicrobio.2018.07.006. Epub 2018 Jul 11.
8
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.几种抗菌药物对表达氨基糖苷类修饰酶的耐甲氧西林金黄色葡萄球菌(MRSA)分离株的体外活性:单用和联合其他药物时的普拉佐米星的效价。
Int J Antimicrob Agents. 2017 Aug;50(2):191-196. doi: 10.1016/j.ijantimicag.2017.01.039. Epub 2017 May 31.
9
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes.普拉唑米星对大多数氨基糖苷类修饰酶仍具有抗生素活性。
ACS Infect Dis. 2018 Jun 8;4(6):980-987. doi: 10.1021/acsinfecdis.8b00001. Epub 2018 Apr 19.
10
A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.一种基于repA的酶联免疫吸附测定法,用于区分接种猪布鲁氏菌2型疫苗的牛与自然感染流产布鲁氏菌和羊布鲁氏菌的牛。
Mol Cell Probes. 2014 Oct-Dec;28(5-6):251-4. doi: 10.1016/j.mcp.2014.06.002. Epub 2014 Jun 15.

引用本文的文献

1
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections.泊沙康唑:一种新型氨基糖苷类药物,用于治疗耐药革兰氏阴性菌感染。
Drugs. 2019 Feb;79(3):243-269. doi: 10.1007/s40265-019-1054-3.
2
Exploring the Molecular Basis for Binding of Inhibitors by Threonyl-tRNA Synthetase from Brucella abortus: A Virtual Screening Study.探索流产布鲁氏菌苏氨酰-tRNA合成酶与抑制剂结合的分子基础:一项虚拟筛选研究
Int J Mol Sci. 2016 Jul 19;17(7):1078. doi: 10.3390/ijms17071078.
3
Antibiotics in the clinical pipeline at the end of 2015.
2015年末处于临床研发阶段的抗生素
J Antibiot (Tokyo). 2017 Jan;70(1):3-24. doi: 10.1038/ja.2016.72. Epub 2016 Jun 29.
4
Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.氨基糖苷类抗生素耐药机制:概述与展望
Medchemcomm. 2016 Jan 1;7(1):11-27. doi: 10.1039/C5MD00344J. Epub 2015 Sep 21.